戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ut requires nitric oxide release to suppress vasoconstricting 20-HETE synthesis.
2  toxin (PTX) (400 ng/ml) for 2 h blocked the vasoconstricting action of adenosine or N(6)-cyclohexyla
3 helin-1 (ET-1) are not limited to its potent vasoconstricting activity.
4 lar endothelium acts as a buffer against the vasoconstricting agent Ang II via release of vasodilator
5 and an increase in sensitivity to adrenergic vasoconstricting agents.
6                        Because of the potent vasoconstricting and mitogenic effects of ET-1 and its i
7 ood flow, at baseline and for modulating the vasoconstricting and neuronal activation responses to co
8                                          The vasoconstricting and profibrotic cytokine endothelin-1 w
9 cular resistance is regulated in part by the vasoconstricting and relaxing effects of compounds such
10                                ACE2 converts vasoconstricting angiotensin II into vasodilating angiot
11 nal glial cells are a possible source of the vasoconstricting ATP.
12 blood flow may involve both vasodilating and vasoconstricting components.
13                                              Vasoconstricting concentration-response relationships we
14 tes during a cocaine challenge prevented its vasoconstricting effects alongside the CBFv decreases, b
15 between endothelium-derived vasodilating and vasoconstricting factors and coronary vasoconstriction i
16 nhanced contractile responses to endothelial vasoconstricting factors, which increase the risk of cor
17 lation and effects of indomethacin-resistant vasoconstricting factors.
18  allowing it to be regulated by a variety of vasoconstricting hormones and neurotransmitters.
19 tive K(+) channels are inhibited by multiple vasoconstricting hormones via the protein kinase C (PKC)
20 of ET-1, an endothelium-derived peptide with vasoconstricting, mitogenic and angiogenic properties, i
21                     Norepinephrine (NE) is a vasoconstricting neurotransmitter released from sympathe
22 al hyperplasia for endothelins (ETs), potent vasoconstricting peptides that also exert growth-promoti
23             These observations indicate that vasoconstricting post-junctional alpha(2)-adrenoceptors
24                                 Although the vasoconstricting properties of cocaine underlie its cere
25  mediated, in part, by the generation of the vasoconstricting prostanoid thromboxane A2 (TXA2).
26                                          The vasoconstricting protein endothelin-1 (ET-1) has been im
27 monary vascular resistance and the pulmonary vasoconstricting response to alveolar hypoxia, suggestin
28 tentiates an exaggerated afferent arteriolar vasoconstricting response to angiotensin II and opens po
29 lled by the balance between vasodilating and vasoconstricting systems that could finely tune local bl
30 levels cause hyperthermia during exercise by vasoconstricting the skin.
31 scle is trans-inhibited by activation of the vasoconstricting thromboxane A(2) prostanoid receptor (T
32 ce in vasodilating (prostacyclin [PGI2]) and vasoconstricting (thromboxane A2 [TxA2]) eicosanoids may
33 lance of several counteracting forces, i.e., vasoconstricting versus vasodilating, growth-promoting v
34 o of Tx-M to PGI-M, used to express relative vasoconstricting vs vasodilating effects, was 24% higher